These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9120401)

  • 1. NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses.
    Doi TS; Takahashi T; Taguchi O; Azuma T; Obata Y
    J Exp Med; 1997 Mar; 185(5):953-61. PubMed ID: 9120401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function.
    Chen CL; Singh N; Yull FE; Strayhorn D; Van Kaer L; Kerr LD
    J Immunol; 2000 Nov; 165(10):5418-27. PubMed ID: 11067893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p65 subunit of NF-kappa B is redundant with p50 during B cell proliferative responses, and is required for germline CH transcription and class switching to IgG3.
    Horwitz BH; Zelazowski P; Shen Y; Wolcott KM; Scott ML; Baltimore D; Snapper CM
    J Immunol; 1999 Feb; 162(4):1941-6. PubMed ID: 9973462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.
    Nishiyama S; Manabe N; Kubota Y; Ohnishi H; Kitanaka A; Tokuda M; Taminato T; Ishida T; Takahara J; Tanaka T
    Int Immunopharmacol; 2005 Apr; 5(4):699-710. PubMed ID: 15710339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of developing B cell survival by RelA-containing NF-kappa B complexes.
    Prendes M; Zheng Y; Beg AA
    J Immunol; 2003 Oct; 171(8):3963-9. PubMed ID: 14530314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment.
    Alcamo E; Mizgerd JP; Horwitz BH; Bronson R; Beg AA; Scott M; Doerschuk CM; Hynes RO; Baltimore D
    J Immunol; 2001 Aug; 167(3):1592-600. PubMed ID: 11466381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
    Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
    Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.
    Beg AA; Sha WC; Bronson RT; Ghosh S; Baltimore D
    Nature; 1995 Jul; 376(6536):167-70. PubMed ID: 7603567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-2 and a contact-mediated signal provided by TCR alpha beta + or TCR gamma delta + CD4+ T cells induce polyclonal Ig production by committed human B cells. Enhancement by IL-5, specific inhibition of IgA synthesis by IL-4.
    van Vlasselaer P; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Mar; 148(6):1674-84. PubMed ID: 1347306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
    Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
    EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells.
    Horwitz BH; Scott ML; Cherry SR; Bronson RT; Baltimore D
    Immunity; 1997 Jun; 6(6):765-72. PubMed ID: 9208848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching.
    Snapper CM; Zelazowski P; Rosas FR; Kehry MR; Tian M; Baltimore D; Sha WC
    J Immunol; 1996 Jan; 156(1):183-91. PubMed ID: 8598461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
    Nishina H; Bachmann M; Oliveira-dos-Santos AJ; Kozieradzki I; Fischer KD; Odermatt B; Wakeham A; Shahinian A; Takimoto H; Bernstein A; Mak TW; Woodgett JR; Ohashi PS; Penninger JM
    J Exp Med; 1997 Sep; 186(6):941-53. PubMed ID: 9294148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice.
    Rosenfeld ME; Prichard L; Shiojiri N; Fausto N
    Am J Pathol; 2000 Mar; 156(3):997-1007. PubMed ID: 10702415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice:roles of NF-kappa B in the activation and differentiation of autoreactive T cells.
    Hilliard B; Samoilova EB; Liu TS; Rostami A; Chen Y
    J Immunol; 1999 Sep; 163(5):2937-43. PubMed ID: 10453042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Ig class switch recombination by NF-kappaB: retroviral expression of RelB in activated B cells inhibits switching to IgG1, but not to IgE.
    Bhattacharya D; Lee DU; Sha WC
    Int Immunol; 2002 Sep; 14(9):983-91. PubMed ID: 12202396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.
    Pioli C; Gatta L; Frasca D; Doria G
    Eur J Immunol; 1999 Mar; 29(3):856-63. PubMed ID: 10092088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective T cells from gld mice play a pivotal role in development of Thy-1.2+B220+ cells and autoimmunity.
    Yasutomo K; Maeda K; Nagata S; Nagasawa H; Okada K; Good RA; Kuroda Y; Himeno K
    J Immunol; 1994 Dec; 153(12):5855-64. PubMed ID: 7527451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.